Title

Patent: Nestorone®/estradiol transdermal gel

Document Type

Patent

Publication Date

2017

Abstract

The invention discloses compositions and methods for ensuring in both women of fertile age where it ensures also a contraception with additional health benefits and in postmenopausal women where it offers a hormonal therapy with additional medical benefits such as the potential for lower risk of thrombosis. The compositions comprising NES as a potent progestational and antiovulatory agent with no androgenic nor estrogenic nor glucocorticoid effect, and combined with estradiol formulated for non-oral transdermal administration as specific daily doses.

DOI

United States Patent 9,682,087

Language

English

US9682087.pdf (1173 kB)

Share

COinS